Excipients Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
0IF3 | B | Eastman Chemical Co. | 2.17 | |
TATE | C | Tate & Lyle Plc | 0.00 | |
0G7B | F | Suedzucker AG | 0.04 |
Related Industries: Packaged Foods
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FLXD | A | Franklin LibertyQ European Dividend UCITS ETF | 1.09 | |
FRXD | A | Franklin LibertyQ European Dividend UCITS ETF | 1.09 | |
FT1K | A | Amundi ETF | 0.94 | |
CUKS | A | iShares MSCI UK Small Cap UCITS ETF | 0.84 | |
GENG | C | UBS (IRL) ETF PLC UBS (IRL) ETF GL GEN EQ HDG GPB ACC | 0.83 |
Compare ETFs
- Excipients
An excipient is a substance formulated alongside the active ingredient of a medication, included for the purpose of long-term stabilization, bulking up solid formulations that contain potent active ingredients in small amounts (thus often referred to as "bulking agents", "fillers", or "diluents"), or to confer a therapeutic enhancement on the active ingredient in the final dosage form, such as facilitating drug absorption, reducing viscosity, or enhancing solubility. Excipients can also be useful in the manufacturing process, to aid in the handling of the active substance concerns such as by facilitating powder flowability or non-stick properties, in addition to aiding in vitro stability such as prevention of denaturation or aggregation over the expected shelf life. The selection of appropriate excipients also depends upon the route of administration and the dosage form, as well as the active ingredient and other factors. A comprehensive classification system based on structure-property-application relationships has been proposed for excipients used in parenteral medications.Pharmaceutical regulations and standards require that all ingredients in drugs, as well as their chemical decomposition products, be identified and shown to be safe. Often, more excipient is found in a final drug formulation than active ingredient, and practically all marketed drugs contain excipients.: 1 As with new drug substances and dosage forms thereof, novel excipients themselves can be patented; sometimes, however, a particular formulation involving them is kept as a trade secret instead (if not easily reverse-engineered).
Recent Comments
- TraderMike on Trades of the Week: Jan 8 - Jan 12, 2024
- Magneto296 on Trades of the Week: Jan 8 - Jan 12, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
From the Blog
Featured Articles